On August 14, Hong Kong Zhongji 1 International Medical Group and Thermo Fisher Scientific jointly announced that the two parties will establish the "Greater China Strategic Cooperation Center" to conduct in-depth cooperation in the field of cell medicine and promote the development of cell management in the world. Promote the development of human health.
According to reports, Thermo Fisher Scientific is a global leader in scientific services (New York Stock Exchange code: TMO), committed to helping customers make the world healthier, cleaner, and safer. The company's main customer types include pharmaceutical and biological companies, hospitals and clinical diagnostic laboratories, universities, scientific research institutes and government agencies, and environmental and industrial process control equipment manufacturers.
Thermo Scientific provides customers with a complete set of laboratory comprehensive solutions including high-end analytical instruments, laboratory equipment, software, services, consumables and reagents. Fisher Scientific provides a series of laboratory equipment, chemicals, and other supplies and services to customers in the fields of health care, scientific research, and safety and education.
Therefore, the cooperation between the two parties is not only business integration, but also an alliance of advanced medical resources. The newly established "Greater China Strategic Cooperation Center" brings together the respective advantages of both parties and will continually consolidating the leading position of the Hong Kong Zhongji 1 International Medical Group in the world's cell management.